Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Bio-Techne Corp (TECH) had Revenue of $1.16B for the most recently reported fiscal year, ending 2024-06-30.

Quarterly Annual

Figures for fiscal year ending 2024-06-30

Income Statement Financials
Revenue	$1.16B
Net Income	$168.10M
Cost of Goods Sold	$389.33M
Gross Profit	$769.73M
Operating Expenses	$952.37M
Operating Income	$206.69M
Non-Operating Income/Expense	$-21.00M
Pre-Tax Income	$185.69M
Normalized Pre-Tax Income	$185.69M
Income after Taxes	$168.10M
Income from Continuous Operations	$168.10M
Consolidated Net Income/Loss	$168.10M
Normalized Income after Taxes	$168.10M
EBIT	$206.69M
EBITDA	$318.40M
Weighted-Average Shares Outstanding (Basic)	157.71M
Weighted-Average Shares Outstanding (Diluted)	160.77M
Earnings per Share (EPS) (Basic)	$1.07
Earnings per Share (EPS) (Diluted)	$1.05
Balance Sheet Financials
Current Assets	$617.42M
Property, Plant, and Equipment	$251.15M
Long-Term Assets	$2.09B
Total Assets	$2.70B
Current Liabilities	$159.38M
Long-Term Debt	$319.00M
Long-Term Liabilities	$475.64M
Total Liabilities	$635.02M
Common Equity	$2.07B
Tangible Shareholders Equity	$589.11M
Shareholders Equity	$2.07B
Common Shares Outstanding	158.22M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$298.98M
Cash Flow from Investing Activities	$-203.03M
Cash Flow from Financial Activities	$-122.40M
Beginning Cash	$180.57M
End Cash	$151.79M
Increase/Decrease in Cash	$-28.78M
Stock-Based Compensation	$38.04M
Common Stock Dividends Paid	$-50.42M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.13
Debt to Equity Ratio	0.15
Gross Margin	66.41%
Operating Margin	17.83%
EBIT Margin	17.83%
EBITDA Margin	27.47%
Pre-Tax Profit Margin	16.02%
Profit Margin	14.50%
Free Cash Flow	$236.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.43
Inventory Turnover	2.17
Receiveable Turnover	4.80
Days Sales in Receivables	76.02
Return on Equity	8.13%
Return on Tangible Equity	28.54%
Return on Assets	6.22%
Return on Investments	7.04%
Book Value Per Share	$13.08
Free Cash Flow per Share	$1.47
Operating Cash Flow per Share	$1.86

Data from Zacks Investment Research, Inc.